Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Other Ref. Standards of Oxymorphone HCl on PharmaCompass.com.

    Client Email Product

    Oxymorphone HCl

    APIs // Active Pharmaceutical Ingredients

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    GLOBAL SALES INFORMATION

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    12
    US DMFs Filed

    US DMFs Filed

    8
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    7
    API REF. PRICE (USD / KG)

    0

    API Market Place

    0

    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    75
    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    868.00

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    49

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    3

    News

    15
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    2
    SERVICES

    0

    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info

    Mallinckrodt Pharmaceuticals

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Oxymorphone Hydrochloride +RC ARS

    PDF Supplier PDF
    URL Supplier Web Content
    4926
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    USP

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Noroxymorphone Hydrochloride CII (50 mg) (4,5alpha-Epox...

      PDF Supplier PDF
      URL Supplier Web Content
      52446-24-9
      50
      mg
      Material Origin- Chemical...
      $890.00
      Catalog #1473002 / R133E0
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
      left grey arrow
      right gray arrow
      • INJECTABLE;INJECTION - 1MG/ML
      • TABLET, EXTENDED RELEASE;ORAL - 10MG
      • TABLET, EXTENDED RELEASE;ORAL - 15MG
      • TABLET, EXTENDED RELEASE;ORAL - 20MG
      • TABLET, EXTENDED RELEASE;ORAL - 30MG
      • TABLET, EXTENDED RELEASE;ORAL - 40MG
      • TABLET, EXTENDED RELEASE;ORAL - 5MG
      • TABLET, EXTENDED RELEASE;ORAL - 7.5MG
      • TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
      • TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
      • TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
      • TABLET, EXTENDED RELEASE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
      • TABLET, EXTENDED RELEASE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
      • TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
      • TABLET, EXTENDED RELEASE;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
      • TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
      • TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
      Ask Us for Pharmaceutical Supplier and Partner
      Ask Us, Find A Supplier / Partner
      No Commissions, No Strings Attached, Get Connected for FREE

      What are you looking for?

      How can we help you?

      The request can't be empty

      Please read our Privacy Policy carefully

      You must agree to the privacy policy

      The name can't be empty
      The company can't be empty.
      The email can't be empty Please enter a valid email.
      The mobile can't be empty
      euroapi-2024-05-06

      Access Virtual Booth

      Contact Supplier

      View Presentation

      Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

      Access Virtual Booth

      Contact Supplier

      View Presentation

      Post Enquiry
      POST ENQUIRY

      Market Place

      Market Place

      PharmaCompass

      Home

      Market Place

      Menu

      Post Enquiry

      Post Enquiry

      Market Place

      Market Place

      Search